Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2100.0000 (-2.33%) ($2100.0000 - $2100.0000) on Thu. Sep. 27, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.6% (three month average) | RSI | 98 | Latest Price | $2100.0000(-2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1% a day on average for past five trading days. | Weekly Trend | CAPR advances 43.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | Factors Impacting CAPR price | CAPR will decline at least -7.8% in a week (0% probabilities). XLU(0%) XLP(0%) VWO(0%) TLT(0%) GLD(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.8% (StdDev 15.6%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $2080(0.96%) | 10 Day Moving Average | $1769.51(18.68%) | 20 Day Moving Average | $1411.05(48.83%) | To recent high | -2.3% | To recent low | 265.2% | Market Cap | $41.365b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |